David Hoffmeister

David Hoffmeister

Wilson Sonsini Goodrich & Rosati

Contact  |  View Bio  |  RSS

Latest Publications

Share:

The Life Sciences Report - Spring 2014

In this issue: - A New Accelerator Takes Digital Health Start-Ups to the Next Level - The Return of the MedTech IPO Market - Is There a Deal in Your Future? A Guide to Navigating Antitrust Waters -...more

5/1/2014 - Digital Health Healthcare IPO Patents SBIRs Startups Venture Funding

FDA Intends to Grant Five Years of Market Exclusivity to Fixed-Dose Combination Drugs Containing One New Drug Substance

Fixed-dose combination drug products are becoming increasingly important in the treatment of patients with diabetes, cardiovascular disease, and infectious disease. Within the last two decades, the U.S. Food and Drug...more

2/27/2014 - Exclusive Dealing Agreements FDA Pharmaceutical Prescription Drugs

The Life Sciences Report - Fall 2013

In this issue: - How to Expedite Examination of a Patent Application - The FDA Releases Final Guidance for Mobile Medical Applications - Creating Value in the Medtech Industry Using a Gender Lens -...more

10/4/2013 - Biotechnology FDA Life Sciences Medical Devices Mobile Apps Patent Applications Patents Pharmaceutical Telemedicine USPTO Venture Capital

The Life Sciences Report - Spring 2013

In this issue: - Best Patent Practices Under the America Invents Act - CMS Issues Final Rule for Implementing Sunshine Act - New IP Litigation Team a Boon for Firm's Life Sciences and Technology...more

6/12/2013 - America Invents Act Civil Monetary Penalty CMS Final Rules Mayo Foundation for Medical Ed Mayo v. Prometheus Patent Reform Patents Sunshine Act Venture Capital

4 Results
|
View per page
Page: of 1